Medical Surveillance Monthly Report (MSMR). Volume 19, Number 3, March 2012

Abstract

After a 12-year hiatus, military recruit training centers resumed administration of adenovirus type 4 and type 7 vaccine, live, oral (adenovirus vaccine) to trainees beginning in October of 2011. Subsequently, rates of febrile respiratory illnesses (FRI) and adenovirus isolations markedly declined. These findings are consistent with those of a placebo-controlled efficacy trial conducted prior to the vaccine s licensure by the U.S. Food and Drug Administration. Continued surveillance will clarify the longer term impact of vaccine use.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Mar 01, 2012
Accession Number
ADA558397

Entities

Organizations

  • Armed Forces Health Surveillance Center

Tags

DTIC Thesaurus Topics

  • Health Services
  • Medical Personnel
  • Military Medicine
  • Pain
  • Psychiatry
  • Vaccines
  • Wounds And Injuries

Fields of Study

  • Biology
  • Medicine

Readers

  • Brain and Cognitive Science; Experimental Psychology; Cognitive Neuroscience
  • Infectious Disease/Epidemiology

Technology Areas

  • Biotechnology